These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34664431)

  • 1. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review.
    McGovern J; Dolan RD; Horgan PG; Laird BJ; McMillan DC
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1408-1417. PubMed ID: 34664431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
    Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer.
    Golder AM; Sin LKE; Alani F; Alasadi A; Dolan R; Mansouri D; Horgan PG; McMillan DC; Roxburgh CS
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2863-2874. PubMed ID: 36218135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer.
    Golder AM; Ferguson M; McMillan P; Mansouri D; Horgan PG; Roxburgh CS; Dolan RD; McGovern J; McMillan DC
    Sci Rep; 2024 Jul; 14(1):15673. PubMed ID: 38977870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-derived body composition: Differential association with disease, age and inflammation in a retrospective cohort study.
    Bradley NA; McGovern J; Dolan RD; Golder AM; Roxburgh CSD; Guthrie GJK; McMillan DC
    PLoS One; 2024; 19(3):e0300038. PubMed ID: 38512880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients.
    Grønberg BH; Valan CD; Halvorsen T; Sjøblom B; Jordhøy MS
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1347-1355. PubMed ID: 31385663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography-based body composition is associated with adverse clinical outcomes among older patients with sepsis in the emergency department.
    Li Q; Shang N; Gao Q; Yang L; Guo S
    Eur Geriatr Med; 2023 Apr; 14(2):353-361. PubMed ID: 36780105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trunk muscle quality and quantity predict the development of metabolic syndrome and the increase in the number of its components in individuals without metabolic syndrome.
    Tanaka M; Okada H; Hashimoto Y; Kumagai M; Nishimura H; Fukui M
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1161-1168. PubMed ID: 32448718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
    Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
    Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
    Liu J; Yu X; Huang X; Lai Q; Chen J
    Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of skeletal muscle abnormalities on tolerance to adjuvant chemotherapy and radiation and outcome in patients with endometrial cancer.
    Ganju RG; TenNapel M; Spoozak L; Chen AM; Hoover A
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):104-112. PubMed ID: 31397078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography.
    van Vugt JLA; Coebergh van den Braak RRJ; Schippers HJW; Veen KM; Levolger S; de Bruin RWF; Koek M; Niessen WJ; IJzermans JNM; Willemsen FEJA
    Clin Nutr; 2018 Oct; 37(5):1707-1714. PubMed ID: 28743427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of weight-adjusted contrast enhancement on computed tomography-derived skeletal muscle measures: a retrospective proof-of-concept comparative study between Danish females and males.
    Brath MSG; Kristensen SV; Sahakyan M; Mark EB; Rasmussen HH; Østergaard LR; Frøkjær JB; Weinreich UM
    Am J Clin Nutr; 2024 Sep; 120(3):696-706. PubMed ID: 38936776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer.
    Grønberg BH; Sjøblom B; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Eur J Clin Nutr; 2019 Jul; 73(7):1069-1076. PubMed ID: 30254241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer.
    Xiao J; Caan BJ; Weltzien E; Cespedes Feliciano EM; Kroenke CH; Meyerhardt JA; Baracos VE; Kwan ML; Castillo AL; Prado CM
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):654-663. PubMed ID: 29675984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study.
    Hanna L; Sellahewa R; Huggins CE; Lundy J; Croagh D
    Sci Rep; 2023 Jun; 13(1):9663. PubMed ID: 37316578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.
    Lin JX; Tang YH; Zhou WX; Desiderio J; Parisi A; Xie JW; Wang JB; Cianchi F; Antonuzzo L; Borghi F; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Staderini F; Marano A; Peluso C; Li P; Zheng CH; Ma YB; Huang CM
    Clin Nutr; 2021 Aug; 40(8):4980-4987. PubMed ID: 34364237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
    Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
    Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between low skeletal muscle mass and low skeletal muscle radiodensity with functional impairment, systemic inflammation, and reduced survival in patients with incurable cancer.
    Calixto-Lima L; Wiegert EVM; Oliveira LC; Chaves GV; Bezerra FF; Avesani CM
    JPEN J Parenter Enteral Nutr; 2023 Feb; 47(2):265-275. PubMed ID: 36325962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.